The Phase III Study Data of Stapokibart for Seasonal Allergic Rhinitis Published in Nature Medicine
CHENGDU, China, April 6, 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" or the "Company") today announced that the prestigious medical journal Nature Medicine has published the results from the Phase III trial of its...
AIM Vaccine reduces losses by nearly 90% in 2024, with the iterative major product series opening up space for explosive growth in performance
HONG KONG, March 31, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published its 2024 Annual Results announcement on March 30, 2025, the company recorded revenues of RMB 1,285 million in 2024, an increase of...
Science! SDU Researchers Identified the Membrane Receptor for Ceramide in Adipocytes
JINAN, China, March 26, 2025 /PRNewswire/ -- Recently, Professor Sun Jinpeng's team at Shandong University and collaborators published a research paper titled "Metabolic signaling of ceramides through the FPR2 receptor inhibits adipocyte...
NEXTBIOMEDICAL, Fast Resorbable Microsphere 'Nexsphere-F' : Clinical Study Results on 155 Patients Published in the JVIR
Safety and Excellent Pain Relief Effect after Musculoskeletal Pain Embolization SEOUL, South Korea, March 17, 2025 /PRNewswire/ -- NEXTBIOMEDICAL CO., LDT, announced that clinical study results of Nexsphere-F™, a resorbable embolic agent for...
AIM Vaccine reported a significant reduction in losses for 2024, with several major products set to launch that are expected to drive substantial revenue growth
HONG KONG, March 17, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 17, 2025, the company's performance in 2024 showed a significant reduction in losses. Preliminary...
BloombergNEF: World's No.1 Inverter Bankability Rating in 2024 for Sungrow
HEFEI, China, March 11, 2025 /PRNewswire/ -- BloombergNEF (BNEF) has published the results of its 2024 PV Module and Inverter Bankability Survey, naming Sungrow the only inverter supplier to receive a global No.1 rating. This marks the fifth time...
AIM Vaccine's Iteratively Upgraded Diploid Rabies Vaccine Approved for Clinical Trials, Showing Significantly Higher Efficacy than Marketed Diploid Rabies Vaccines
HONG KONG, March 10, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 9, 2025, the company's research and development of a diploid rabies vaccine has recently received the...
SKF Annual Report 2024 published online; significant decarbonization milestone reached
GOTHENBURG, Sweden, March 7, 2025 /PRNewswire/ -- AB SKF has today published its Annual and Sustainability Report 2024 on the Group's website. The Report focuses on SKF's value creation activities for customers, shareholders, and other stakeholders...
Akeso Announces The Publication of Its Phase III Clinical Trial Results for Ivonescimab in Head-to-Head Comparison with Pembrolizumab in The Lancet
HONG KONG, March 7, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that the groundbreaking results of the Phase III clinical study (HARMONi-2/AK112-303) of its first-in-class PD-1/VEGF bispecific...
CGTN: 99.9% handled: How CPPCC proposals work in consultative democracy
CGTN published an article showing how China's top political advisory body plays its role in the whole process of people's democracy and highlighting how it facilitates Chinese modernization. BEIJING, March 4, 2025 /PRNewswire/ -- As a political...